, Singapore
319 views
/bolttech

bolttech appoints new non-executive director

She brings over a decade of experience in private equity and technology investments.

Singapore-headquartered bolttech has appointed Ridhi Chaudhary, Chief Investment Officer of Dragon Fund by Liquidity and MUFG, as a Non-Executive Director. 

The appointment follows bolttech’s recent Series C funding round led by Dragon Fund.  

Chaudhary brings over a decade of experience in private equity and technology investments, specialising in sectors such as technology, healthcare, and sustainability across Singapore, India, and the United States. 

Before joining Dragon Fund, Chaudhary spent nine years at Goldman Sachs in its Asset Management division, where she managed a private equity portfolio worth over $2b. 

During her tenure, she invested in companies including ReNew, Antuit, Aragen, Cyfirma, Biocon Biologics, and Good Host Spaces, and served on the boards of several of these firms.  

Prior to Goldman Sachs, Chaudhary was a private equity investor at GIC, Singapore’s sovereign wealth fund, on its direct investments team. 

She began her career as a management consultant at Boston Consulting Group. Chaudhary holds a Bachelor’s degree in Electrical Engineering from IIT Delhi.

 

Follow the link s for more news on

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.